Related Experiment Videos
Thoracoscopic cardiomyotomy for achalasia
1St.Vincent's Hospital, Melbourne, Victoria, Australia.
The Australian and New Zealand Journal of Surgery
|February 1, 1996
Summary
Thoracoscopic cardiomyotomy offers a safe and effective treatment for achalasia, especially for patients who failed prior balloon dilatation. This minimally invasive approach resulted in excellent outcomes and short hospital stays.
Area of Science:
- Gastroenterology
- Minimally Invasive Surgery
- Thoracic Surgery
Background:
- Achalasia is a rare esophageal motility disorder.
- Previous treatments like balloon dilatation can be ineffective for some patients.
- Surgical intervention is often necessary for refractory achalasia.
Purpose of the Study:
- To evaluate the efficacy and safety of thoracoscopic cardiomyotomy for achalasia.
- To assess outcomes in patients with prior failed treatments.
Main Methods:
- Prospective study of 12 achalasia patients undergoing thoracoscopic cardiomyotomy.
- Seven patients had prior unsatisfactory balloon dilatation.
- All procedures were completed thoracoscopically without conversion to thoracotomy.
Main Results:
- Successful procedure in all 12 patients.
- Minimal morbidity and an average postoperative stay of 4 days.
- Good to excellent functional results in 11 patients; fair in one.
Conclusions:
- Thoracoscopic cardiomyotomy is a safe and effective treatment for achalasia.
- It provides excellent outcomes, even in patients with prior treatment failures.
- The minimally invasive approach leads to reduced morbidity and shorter hospitalizations.